'Urology: Today's Advances, Tomorrow's Clinical Practice', Cannes, November 2003. Current thinking in prostatic diseases: insights into dual 5alpha-reductase inhibitor therapy in BPH and prostate cancer.
Fitzpatrick
J M
JM
Mater Misercordiae Hospital, Ireland.
D018890:Chemoprevention; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D014572:Urology / Q000639:trends*